• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Genesis HealthCare Announces Leadership Change

    1/5/21 8:30:00 AM ET
    $GEN
    Computer Software: Prepackaged Software
    Technology
    Get the next $GEN alert in real time by email

    George V. Hager, Jr. Retires as CEO and Director
    Board of Directors Appoints Current Chairman, Robert H. Fish as New CEO

    KENNETT SQUARE, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, announced today that George V. Hager, Jr. has decided to retire as the Company’s Chief Executive Officer (CEO) and Director. Genesis’ Board of Directors has appointed the Company’s current Chairman of the Board, Robert (“Bob”) H. Fish as CEO, effective today, January 5, 2021. Bob will remain Chairman of the Board.

    Mr. Fish, a member of the Genesis Board of Directors since 2013 and Chairman since 2017, has extensive experience as a healthcare company executive, including significant experience in the long-term care industry. Mr. Hager will continue in a senior advisory role to the Company’s Board of Directors.

    “The Board and I would like to thank George for 28 years of unwavering leadership and tireless commitment and service to the Company, its employees, patients, residents and families, and to the entire post-acute industry,” said Mr. Fish. “We are pleased that George will serve as a senior advisor to me and the Board of Directors, assisting with the transition, ongoing restructuring efforts and continued advocacy for the Company and the industry.”

    “We are fortunate to have Bob step in as a leader with significant experience both inside and outside of Genesis. He brings expertise and continuity essential to Genesis as we continue to navigate the impact of COVID-19 and explore avenues to strengthen the Company financially,” said Mr. Hager. “It has been my honor to serve and lead this Company over the last 17 years. I would like to thank the senior management team as well as our Center leaders and caregivers for their dedication and commitment to Genesis and our patients, residents and families. I am also proud to have had the opportunity to bring our founder, Michael R. Walker’s, vision to fruition these many years,” continued Mr. Hager.

    “I am pleased to become Genesis’ Chief Executive Officer and am excited to lead the Company as we look to emerge from the pandemic and navigate to recovery,” said Mr. Fish. “I look forward to sharing my vision and direction for the Company in the coming months.”

    Mr. Fish has a long history with Genesis and its predecessor companies Genesis HealthCare Corp. and Genesis Health Ventures, Inc. He has served on its current Board of Directors since 2013 when he joined Skilled Healthcare Group, Inc. as CEO until its merger with Genesis in 2015. Additionally, from 2003 to 2007, he served as Lead Director of Genesis HealthCare Corp., and from 2002 to 2003 he served as Chairman and Chief Executive Officer of Genesis Health Ventures, Inc. During his career, Mr. Fish has served as Chairman, President or CEO of several other healthcare companies. Most recently, from 2018 to July 2020, he served as President, CEO and Director of Quorum Health Corporation, a publicly held operator of general acute care hospitals and outpatient services. From 2008 to 2012, he served as Chairman of REACH Medical Holdings, a regional air medical transport company, from 2005 to 2006 he served as Executive Chairman of Coram, Inc., a large home infusion provider. Previously, Mr. Fish served as President and Chief Executive Officer of St. Joseph Health System—Sonoma County and Valleycare Health System, both regional hospital systems in Northern California.

    About Genesis HealthCare
    Genesis HealthCare is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's largest post-acute care companies, providing services to more than 325 skilled nursing facilities and assisted/senior living communities in 24 states nationwide. Genesis subsidiaries also supply rehabilitation therapy to approximately 1,100 healthcare providers in 44 states, the District of Columbia and China.  References made in this release to "Genesis," "the Company," "we," "us" and "our" refer to Genesis Healthcare, Inc. and each of its wholly-owned companies. Visit our website at www.genesishcc.com.

    Genesis Healthcare Contact:
    Investor Relations
    610-925-2000


    Get the next $GEN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GEN

    DatePrice TargetRatingAnalyst
    3/18/2025Equal-Weight
    Morgan Stanley
    12/4/2024$36.00Buy
    UBS
    10/24/2024$35.00Overweight
    Wells Fargo
    6/7/2024$28.00 → $27.00Overweight → Equal-Weight
    Morgan Stanley
    4/11/2024$28.00 → $25.00Overweight → Equal Weight
    Barclays
    11/21/2023$23.00 → $26.00Equal-Weight → Overweight
    Morgan Stanley
    11/16/2023$25.00Buy
    BofA Securities
    5/19/2023$27.00Outperform
    Evercore ISI
    More analyst ratings

    $GEN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Q1/2025 Gen Threat Report Reveals AI-Driven Scams Redefining Cybercrime

      Gen Protects Millions of People as Breached Personal Information, Phishing Reports, Fake Browser Update Scams, and Scam-Yourself Attacks Are on the Rise TEMPE, Ariz. and PRAGUE, May 28, 2025 /PRNewswire/ -- Gen (NASDAQ:GEN), a global leader powering Digital Freedom with a family of trusted brands including Norton, Avast, LifeLock, MoneyLion and more, today released its Q1/2025 Gen Threat Report, highlighting the most significant shifts shaping the global Cyber Safety landscape observed between January and March 2025. Key report findings include a 186% surge in breached persona

      5/28/25 9:00:00 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Meet Norton Neo: The First Safe AI-Native Browser Now in Early Access

      Norton combines the power of AI with Norton expertise to redefine the way we experience the digital world TEMPE, Ariz. and PRAGUE, May 22, 2025 /PRNewswire/ -- Today, Norton, a trusted brand part of Gen (NASDAQ:GEN), unveiled its new, innovative browser designed from the ground up with advanced artificial intelligence, Norton Neo. Neo brings together a powerful combination of AI-native intelligence and world-class safety protection, making it the first browser truly built to reimagine how we experience the web with a safer, smarter internet. "With Norton Neo, we're not just building another browser; we're reimagining how you will interact with the digital unive

      5/22/25 9:00:00 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Gen Announces Board Transitions, Welcomes John Chrystal as Peter Feld Departs

      TEMPE, Ariz. and PRAGUE, May 15, 2025 /PRNewswire/ -- Gen Digital Inc. (NASDAQ:GEN), a global leader dedicated to powering Digital Freedom, today announced the departure of Peter Feld from its Board of Directors, following his impactful tenure that began in 2018. With this departure, Gen welcomes John Chrystal, former member of MoneyLion's Board of Directors, who joins the Gen Board as the Company accelerates its innovation and focus on financial wellness. Peter Feld has been an extraordinary force behind Gen's evolution. Joining the board of Symantec in 2018, Peter played an

      5/15/25 5:37:00 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology

    $GEN
    Leadership Updates

    Live Leadership Updates

    See more
    • Gen Announces Board Transitions, Welcomes John Chrystal as Peter Feld Departs

      TEMPE, Ariz. and PRAGUE, May 15, 2025 /PRNewswire/ -- Gen Digital Inc. (NASDAQ:GEN), a global leader dedicated to powering Digital Freedom, today announced the departure of Peter Feld from its Board of Directors, following his impactful tenure that began in 2018. With this departure, Gen welcomes John Chrystal, former member of MoneyLion's Board of Directors, who joins the Gen Board as the Company accelerates its innovation and focus on financial wellness. Peter Feld has been an extraordinary force behind Gen's evolution. Joining the board of Symantec in 2018, Peter played an

      5/15/25 5:37:00 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Genesis HealthCare Announces Leadership Change

      George V. Hager, Jr. Retires as CEO and DirectorBoard of Directors Appoints Current Chairman, Robert H. Fish as New CEO KENNETT SQUARE, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, announced today that George V. Hager, Jr. has decided to retire as the Company’s Chief Executive Officer (CEO) and Director. Genesis’ Board of Directors has appointed the Company’s current Chairman of the Board, Robert (“Bob”) H. Fish as CEO, effective today, January 5, 2021. Bob will remain Chairman of the Board. Mr. Fish, a member of the Genesis Board of Directors since 2013 and Cha

      1/5/21 8:30:00 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology

    $GEN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley resumed coverage on Gen Digital

      Morgan Stanley resumed coverage of Gen Digital with a rating of Equal-Weight

      3/18/25 8:39:33 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • UBS initiated coverage on Gen Digital with a new price target

      UBS initiated coverage of Gen Digital with a rating of Buy and set a new price target of $36.00

      12/4/24 7:38:07 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Wells Fargo initiated coverage on Gen Digital with a new price target

      Wells Fargo initiated coverage of Gen Digital with a rating of Overweight and set a new price target of $35.00

      10/24/24 6:32:41 AM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology

    $GEN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Dangeard Frank E covered exercise/tax liability with 145 shares, decreasing direct ownership by 0.08% to 185,154 units (SEC Form 4)

      4 - Gen Digital Inc. (0000849399) (Issuer)

      6/3/25 7:02:34 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • Director Chrystal John C was granted 2,901 shares (SEC Form 4)

      4 - Gen Digital Inc. (0000849399) (Issuer)

      5/19/25 7:23:39 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 3 filed by new insider Chrystal John C

      3 - Gen Digital Inc. (0000849399) (Issuer)

      5/19/25 6:59:21 PM ET
      $GEN
      Computer Software: Prepackaged Software
      Technology